A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Halothane
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Levocetirizine.
Halothane
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Levocetirizine.
Halothane
Chlormezanone
The risk or severity of adverse effects can be increased when Chlormezanone is combined with Levocetirizine.
Halothane
Cyclizine
The risk or severity of adverse effects can be increased when Cyclizine is combined with Levocetirizine.
Halothane
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Levocetirizine.
Halothane
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Levocetirizine.
Halothane
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Levocetirizine.
Halothane
Eliglustat
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Eliglustat.
Halothane
Terodiline
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Terodiline.
Halothane
Macimorelin
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Macimorelin.
Halothane
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Deutetrabenazine.
Halothane
Glasdegib
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Glasdegib.
Halothane
Ribociclib
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ribociclib.
Halothane
Ivabradine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ivabradine.
Halothane
Lumefantrine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Lumefantrine.
Halothane
Artemether
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Artemether.
Halothane
Asenapine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Asenapine.
Halothane
Iloperidone
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Iloperidone.
Halothane
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Tetrabenazine.
Halothane
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Zuclopenthixol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3